Gastroenterology and Hepatology

Track22:Targeting Genetic Pathways in Gastrointestinal Inflammation

Gastrointestinal inflammation, a hallmark of diseases such as Inflammatory Bowel Disease (IBD), Crohn's disease, and ulcerative colitis, is driven by complex genetic and immune system interactions. Understanding the genetic pathways involved in these inflammatory processes is essential for developing more effective and targeted therapies. This track will focus on the latest advancements in identifying and targeting the specific genetic pathways that contribute to gastrointestinal inflammation.

In addition, the role of epigenetics, microRNAs, and immune system modulation in gastrointestinal inflammation will be explored. Advances in gene editing technologies, such as CRISPR-Cas9, are opening new doors for directly manipulating these genetic pathways, potentially leading to the development of more precise, long-lasting treatments.

This session will highlight the most recent breakthroughs in genetic research related to gastrointestinal inflammation, showcasing novel therapeutic strategies and discussing the challenges and future directions for targeting genetic pathways to improve patient outcomes in GI inflammatory diseases.